Abacus Medicine Pharmaceuticals ApS
CVR 39192063 · Private limited company (ApS) · Active · Low risk
Abacus Medicine Pharmaceuticals ApS is a Private limited company (ApS), founded on , based in København V. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.9% over the next 12 months, which is 0.6 times the average for Danish companies. 8 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 14.3m and a net result of DKK -5.5m. CEO: Flemming Wagner.
Bankruptcy risk for Abacus Medicine Pharmaceuticals ApS
0.6 × the average (1.41%) · higher risk than 70% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 39192063
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (8 years)
- Address
- c/o Abacus Medicine A/S, Kalvebod Brygge 35
1560 København V - Municipality
- København
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 500k
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 2 of 8 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 5.4% |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 6 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -80k | DKK -64k | DKK -73k |
| Net profit | DKK -5.5m | DKK -2.4m | DKK 1.4m |
| Equity | DKK 14.3m | DKK 19.7m | DKK 22.2m |
| Total assets | DKK 261.9m | DKK 55.9m | DKK 127.2m |
| Cash | – | DKK 0 | – |
| Short-term debt | DKK 151.3m | DKK 36.2m | – |
| Avg. employees | 0 | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Den uafhængige revisors erklæring · EY Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 181 | ||
| 1 Jan 2024 – 31 Dec 2024 | 162 | ||
| 1 Jan 2023 – 31 Dec 2023 | 168 | ||
| 1 Jan 2022 – 31 Dec 2022 | 166 | ||
| 1 Jan 2021 – 31 Dec 2021 | 182 | ||
| 1 Jan 2020 – 31 Dec 2020 | 186 | Late | |
| 1 Jan 2019 – 31 Dec 2019 | 247 | Late | |
| 21 Dec 2017 – 31 Dec 2018 | 155 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Flemming Wagner | Current | |
| Owner (100%) | ABACUS MEDICINE A/S | Current | |
| Auditor | EY Godkendt Revisionspartnerselskab | Current | |
| Founder | ABACUS MEDICINE A/S | Current |
The CEOs' other companies
Flemming Wagner – 8 other companies
- ABACUS MEDICINE A/S Active
- DayDose ApS Active
- FTW Holding ApS Active
- FTW Invest ApS Active
- MEDCOMB ApS Fusioneret
- RAMCON A/S Active
- Ropca A/S Active
- Wagner Family Holding ApS Active
Address history (1 moves)
| c/o Abacus Medicine A/S, Kalvebod Brygge 35, 1560 København V | |
| c/o Abacus Medicine A/S, Vesterbrogade 149, 1620 København V |
Former names
| Abacus Medicine Pharmaceuticals ApS | – now |
| Abacus Medicine Pharma Services ApS | – |
| Aposave ApS | – |
Other companies at the same address
- ABACUS MEDICINE A/S Active
- DayDose ApS Active
- Evocative ApS Active
- FTW Holding ApS Active
- FTW Invest ApS Active
- Wagner Family Holding ApS Active
Similar companies in København
- ALFASCAN ApS København K
- LUNDBECK PHARMA A/S Valby
- ASTRAZENECA A/S København V
- Sundvik ApS Vanløse
- DEXCOM DENMARK, ApS København Ø
- Nitrilehandsker.dk ApS Valby
- DePuy Synthes (Denmark) ApS København K
- ELSE NORDICS APS København S
- MSD Animal Health A/S København V
- DentFriends ApS København S
- Sanad Health ApS København N
- Venteus Medical Devices (ROW) ApS København Ø
Questions and answers about Abacus Medicine Pharmaceuticals ApS
Has Abacus Medicine Pharmaceuticals ApS gone bankrupt?
No, Abacus Medicine Pharmaceuticals ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Abacus Medicine Pharmaceuticals ApS?
Our model estimates a bankruptcy risk of 0.9% over the next 12 months (low risk), which is 0.6 times the average for Danish companies.
Who is the CEO of Abacus Medicine Pharmaceuticals ApS?
Flemming Wagner is the CEO of Abacus Medicine Pharmaceuticals ApS.
Who is the auditor of Abacus Medicine Pharmaceuticals ApS?
Abacus Medicine Pharmaceuticals ApS most recently used EY Godkendt Revisionspartnerselskab.
When was Abacus Medicine Pharmaceuticals ApS founded?
Abacus Medicine Pharmaceuticals ApS was founded on 21 December 2017.
What is the equity of Abacus Medicine Pharmaceuticals ApS?
Equity was DKK 14.3m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.